Please login to the form below

Not currently logged in
Email:
Password:

Roche Cobas

This page shows the latest Roche Cobas news and features for those working in and with pharma, biotech and healthcare.

Boehringer cancer drug on course for NHS use in UK

Boehringer cancer drug on course for NHS use in UK

Boehringer's drug will face two EGFR inhibitors already approved by NICE for NHS use: AstraZeneca and Teva's Iressa(gefitinib) and Roche's Tarceva(erlotinib). ... Recommended devices included Roche's cobas EGFR Mutation Test and Qiagen's therascreen EGFR

Latest news

  • Boehringer to work with Roche on cancer diagnostics Boehringer to work with Roche on cancer diagnostics

    Boehringer to work with Roche on cancer diagnostics. Will collaborate with Roche subsidiary Ventana Medical Systems. ... Boehringer's choice of Roche-owned Ventana to co-develop the diagnostic kits is an interesting one, considering Roche itself has the

  • NICE recommends tests to detect lung cancer mutation NICE recommends tests to detect lung cancer mutation

    These include Boehringer Ingelheim's Giotrif/ Gilotrif (afatinib) and Roche's Tarceva (erlotinib), both of which have specific approvals for use in patients with EGFR. ... Both medicines were also approved by the US Food and Drug Administration (FDA)

  • Boehringer breaks into oncology with FDA approval Boehringer breaks into oncology with FDA approval

    Roche and Astellas also received fast-track status in January for their cancer drug Tarceva to cover first-line treatment of NSCLC, receiving approval for this expanded indication in March. ... Tarceva was approved alongside Roche's own the cobas EGFR

  • Roche pays $220m for blood-testing company Roche pays $220m for blood-testing company

    Roche pays $220m for blood-testing company. Boosts diagnostics business with acquisition of Constitution Medical Investors. ... The CMI acquisition will boost this division's current efforts in blood testing, which includes Roche's cobas series of

  • US FDA approves Roche's assay as first blood test to diagnose diabetes US FDA approves Roche's assay as first blood test to diagnose diabetes

    US FDA approves Roche's assay as first blood test to diagnose diabetes. ... Roche's Cobas Integra 800 Tina-quant HbA1cDx assay and other similar tools to measure blood sugar are already used to monitor the glucose control of people with diabetes, but

More from news
Approximately 1 fully matching, plus 15 partially matching documents found.

Latest Intelligence

  • Diagnostics are rising up the pharma value chain Diagnostics are rising up the pharma value chain

    lung cancer, which was backed together with Roche Diagnostics' cobas EGFR Mutation Test. ... As evidence of this, Roche Diagnostics' collaborative work includes a deal to provide diagnostics for Boehringer's cancer portfolio.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Just::Health Communications

Just:: is a different kind of healthcare communications agency. Since 2006, we’ve been collaborating with clients around the world to...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics